▶ 調査レポート

世界の生物製剤開発市場予測(~2024年)

• 英文タイトル:Global Biologics Drug Development Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の生物製剤開発市場予測(~2024年) / Global Biologics Drug Development Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024 / B-GIR09D0586資料のイメージです。• レポートコード:B-GIR09D0586
• 出版社/出版日:GlobalInfoResearch / 2019年9月4日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、118ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、生物製剤開発の世界市場について調べ、まとめました。種類別セグメントは、臨床製造、製剤開発、バイオアッセイ開発、分析サービス等、用途別セグメントは、社内、アウトソース、製薬過剰等に区分しました。生物製剤開発の世界市場概観、メーカー動向、メーカー別生物製剤開発シェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・生物製剤開発の市場概観
・生物製剤開発の企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・生物製剤開発の企業別販売動向、市場シェア、市場集中度、競争動向
・生物製剤開発の世界市場規模
・生物製剤開発の北米市場分析(アメリカ、カナダ、メキシコ等)
・生物製剤開発のアメリカ市場規模推移
・生物製剤開発のカナダ市場規模推移
・生物製剤開発のメキシコ市場規模推移
・生物製剤開発のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・生物製剤開発のドイツ市場規模推移
・生物製剤開発のイギリス市場規模推移
・生物製剤開発のロシア市場規模推移
・生物製剤開発のアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・生物製剤開発の日本市場規模推移
・生物製剤開発の中国市場規模推移
・生物製剤開発の韓国市場規模推移
・生物製剤開発のインド市場規模推移
・生物製剤開発の東南アジア市場規模推移
・生物製剤開発の南米市場分析(ブラジル、アルゼンチン等)
・生物製剤開発の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・生物製剤開発の種類別分析/販売量、売上、市場シェア(臨床製造、製剤開発、バイオアッセイ開発、分析サービス)
・生物製剤開発の用途別分析/市場規模(社内、アウトソース、製薬過剰)
・生物製剤開発の市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・生物製剤開発の販売チャネル・代理店・貿易業者・ディーラー分析

Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.

Scope of the Report:
The global Biologics Drug Development market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biologics Drug Development.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Biologics Drug Development market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biologics Drug Development market by product type and applications/end industries.

Market Segment by Companies, this report covers
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services

Market Segment by Applications, can be divided into
In-House
Outsource
Pharma Excess

レポート目次

Table of Contents

1 Biologics Drug Development Market Overview
1.1 Product Overview and Scope of Biologics Drug Development
1.2 Classification of Biologics Drug Development by Types
1.2.1 Global Biologics Drug Development Revenue Comparison by Types (2019-2024)
1.2.2 Global Biologics Drug Development Revenue Market Share by Types in 2018
1.2.3 Clinical Manufacturing
1.2.4 Formulation Development
1.2.5 Bioassay Development
1.2.6 Analytical Services
1.3 Global Biologics Drug Development Market by Application
1.3.1 Global Biologics Drug Development Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 In-House
1.3.3 Outsource
1.3.4 Pharma Excess
1.4 Global Biologics Drug Development Market by Regions
1.4.1 Global Biologics Drug Development Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Biologics Drug Development Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologics Drug Development Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologics Drug Development Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Biologics Drug Development Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologics Drug Development Status and Prospect (2014-2024)
1.5 Global Market Size of Biologics Drug Development (2014-2024)
2 Manufacturers Profiles
2.1 Abbvie
2.1.1 Business Overview
2.1.2 Biologics Drug Development Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbvie Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Biologics Drug Development Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Biologics Drug Development Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.4 Charles River Laboratories
2.4.1 Business Overview
2.4.2 Biologics Drug Development Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Charles River Laboratories Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.5 Catalent
2.5.1 Business Overview
2.5.2 Biologics Drug Development Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Catalent Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.6 Lonza Group
2.6.1 Business Overview
2.6.2 Biologics Drug Development Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lonza Group Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.7 Amgen
2.7.1 Business Overview
2.7.2 Biologics Drug Development Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Amgen Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Biologics Drug Development Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
3 Global Biologics Drug Development Market Competition, by Players
3.1 Global Biologics Drug Development Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Biologics Drug Development Players Market Share
3.2.2 Top 10 Biologics Drug Development Players Market Share
3.3 Market Competition Trend
4 Global Biologics Drug Development Market Size by Regions
4.1 Global Biologics Drug Development Revenue and Market Share by Regions
4.2 North America Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.3 Europe Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.5 South America Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
5 North America Biologics Drug Development Revenue by Countries
5.1 North America Biologics Drug Development Revenue by Countries (2014-2019)
5.2 USA Biologics Drug Development Revenue and Growth Rate (2014-2019)
5.3 Canada Biologics Drug Development Revenue and Growth Rate (2014-2019)
5.4 Mexico Biologics Drug Development Revenue and Growth Rate (2014-2019)
6 Europe Biologics Drug Development Revenue by Countries
6.1 Europe Biologics Drug Development Revenue by Countries (2014-2019)
6.2 Germany Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.3 UK Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.4 France Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.5 Russia Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.6 Italy Biologics Drug Development Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Biologics Drug Development Revenue by Countries
7.1 Asia-Pacific Biologics Drug Development Revenue by Countries (2014-2019)
7.2 China Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.3 Japan Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.4 Korea Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.5 India Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Biologics Drug Development Revenue and Growth Rate (2014-2019)
8 South America Biologics Drug Development Revenue by Countries
8.1 South America Biologics Drug Development Revenue by Countries (2014-2019)
8.2 Brazil Biologics Drug Development Revenue and Growth Rate (2014-2019)
8.3 Argentina Biologics Drug Development Revenue and Growth Rate (2014-2019)
8.4 Colombia Biologics Drug Development Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Biologics Drug Development by Countries
9.1 Middle East and Africa Biologics Drug Development Revenue by Countries (2014-2019)
9.2 Saudi Arabia Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.3 UAE Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.4 Egypt Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.5 Nigeria Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.6 South Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
10 Global Biologics Drug Development Market Segment by Type
10.1 Global Biologics Drug Development Revenue and Market Share by Type (2014-2019)
10.2 Global Biologics Drug Development Market Forecast by Type (2019-2024)
10.3 Clinical Manufacturing Revenue Growth Rate (2014-2024)
10.4 Formulation Development Revenue Growth Rate (2014-2024)
10.5 Bioassay Development Revenue Growth Rate (2014-2024)
10.6 Analytical Services Revenue Growth Rate (2014-2024)
11 Global Biologics Drug Development Market Segment by Application
11.1 Global Biologics Drug Development Revenue Market Share by Application (2014-2019)
11.2 Biologics Drug Development Market Forecast by Application (2019-2024)
11.3 In-House Revenue Growth (2014-2019)
11.4 Outsource Revenue Growth (2014-2019)
11.5 Pharma Excess Revenue Growth (2014-2019)
12 Global Biologics Drug Development Market Size Forecast (2019-2024)
12.1 Global Biologics Drug Development Market Size Forecast (2019-2024)
12.2 Global Biologics Drug Development Market Forecast by Regions (2019-2024)
12.3 North America Biologics Drug Development Revenue Market Forecast (2019-2024)
12.4 Europe Biologics Drug Development Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Biologics Drug Development Revenue Market Forecast (2019-2024)
12.6 South America Biologics Drug Development Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Biologics Drug Development Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Biologics Drug Development Picture
Table Product Specifications of Biologics Drug Development
Table Global Biologics Drug Development and Revenue (Million USD) Market Split by Product Type
Figure Global Biologics Drug Development Revenue Market Share by Types in 2018
Figure Clinical Manufacturing Picture
Figure Formulation Development Picture
Figure Bioassay Development Picture
Figure Analytical Services Picture
Table Global Biologics Drug Development Revenue (Million USD) by Application (2014-2024)
Figure Biologics Drug Development Revenue Market Share by Applications in 2018
Figure In-House Picture
Figure Outsource Picture
Figure Pharma Excess Picture
Table Global Market Biologics Drug Development Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Biologics Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Biologics Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Biologics Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Biologics Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Biologics Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Biologics Drug Development Revenue (Million USD) and Growth Rate (2014-2024)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Biologics Drug Development Type and Applications
Table Abbvie Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Biologics Drug Development Type and Applications
Table Allergan Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Biologics Drug Development Type and Applications
Table Boehringer Ingelheim Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table Charles River Laboratories Biologics Drug Development Type and Applications
Table Charles River Laboratories Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Catalent Basic Information, Manufacturing Base and Competitors
Table Catalent Biologics Drug Development Type and Applications
Table Catalent Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Lonza Group Basic Information, Manufacturing Base and Competitors
Table Lonza Group Biologics Drug Development Type and Applications
Table Lonza Group Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Biologics Drug Development Type and Applications
Table Amgen Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Biologics Drug Development Type and Applications
Table Sanofi Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
Table Global Biologics Drug Development Revenue (Million USD) by Players (2014-2019)
Table Global Biologics Drug Development Revenue Share by Players (2014-2019)
Figure Global Biologics Drug Development Revenue Share by Players in 2017
Figure Global Biologics Drug Development Revenue Share by Players in 2018
Figure Global Top 5 Players Biologics Drug Development Revenue Market Share in 2018
Figure Global Top 10 Players Biologics Drug Development Revenue Market Share in 2018
Figure Global Biologics Drug Development Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Biologics Drug Development Revenue (Million USD) by Regions (2014-2019)
Table Global Biologics Drug Development Revenue Market Share by Regions (2014-2019)
Figure Global Biologics Drug Development Revenue Market Share by Regions (2014-2019)
Figure Global Biologics Drug Development Revenue Market Share by Regions in 2018
Figure North America Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Europe Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure South America Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table North America Biologics Drug Development Revenue by Countries (2014-2019)
Table North America Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure North America Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure North America Biologics Drug Development Revenue Market Share by Countries in 2018
Figure USA Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Canada Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Mexico Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table Europe Biologics Drug Development Revenue (Million USD) by Countries (2014-2019)
Figure Europe Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure Europe Biologics Drug Development Revenue Market Share by Countries in 2018
Figure Germany Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure UK Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure France Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Russia Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Italy Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Biologics Drug Development Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Biologics Drug Development Revenue Market Share by Countries in 2018
Figure China Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Japan Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Korea Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure India Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table South America Biologics Drug Development Revenue by Countries (2014-2019)
Table South America Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure South America Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure South America Biologics Drug Development Revenue Market Share by Countries in 2018
Figure Brazil Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Argentina Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Colombia Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Biologics Drug Development Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Biologics Drug Development Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Biologics Drug Development Revenue Market Share by Countries in 2018
Figure Saudi Arabia Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure UAE Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Egypt Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure Nigeria Biologics Drug Development Revenue and Growth Rate (2014-2019)
Figure South Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
Table Global Biologics Drug Development Revenue (Million USD) by Type (2014-2019)
Table Global Biologics Drug Development Revenue Share by Type (2014-2019)
Figure Global Biologics Drug Development Revenue Share by Type (2014-2019)
Figure Global Biologics Drug Development Revenue Share by Type in 2019
Table Global Biologics Drug Development Revenue Forecast by Type (2019-2024)
Figure Global Biologics Drug Development Market Share Forecast by Type (2019-2024)
Figure Global Clinical Manufacturing Revenue Growth Rate (2014-2019)
Figure Global Formulation Development Revenue Growth Rate (2014-2019)
Figure Global Bioassay Development Revenue Growth Rate (2014-2019)
Figure Global Analytical Services Revenue Growth Rate (2014-2019)
Table Global Biologics Drug Development Revenue by Application (2014-2019)
Table Global Biologics Drug Development Revenue Share by Application (2014-2019)
Figure Global Biologics Drug Development Revenue Share by Application (2014-2019)
Figure Global Biologics Drug Development Revenue Share by Application in 2019
Table Global Biologics Drug Development Revenue Forecast by Application (2019-2024)
Figure Global Biologics Drug Development Market Share Forecast by Application (2019-2024)
Figure Global In-House Revenue Growth Rate (2014-2019)
Figure Global Outsource Revenue Growth Rate (2014-2019)
Figure Global Pharma Excess Revenue Growth Rate (2014-2019)
Figure Global Biologics Drug Development Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Biologics Drug Development Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Biologics Drug Development Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Biologics Drug Development Revenue Market Forecast (2019-2024)
Figure Europe Biologics Drug Development Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Biologics Drug Development Revenue Market Forecast (2019-2024)
Figure South America Biologics Drug Development Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Biologics Drug Development Revenue Market Forecast (2019-2024)